Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diabetes and Neuroaxonal Damage in Parkinson's Disease.
Vijiaratnam N, Lawton M, Real R, Heslegrave AJ, Guo T, Athauda D, Gandhi S, Girges C, Ben-Shlomo Y, Zetterberg H, Grosset DG, Morris HR, Foltynie T; PRoBaND Clinical Consortium. Vijiaratnam N, et al. Among authors: girges c. Mov Disord. 2022 Jul;37(7):1568-1569. doi: 10.1002/mds.29067. Mov Disord. 2022. PMID: 35856732 Free PMC article. No abstract available.
Might it Be Possible to Assess Rigidity in PD Patients Remotely?
Sibley KG, Girges C, Milabo C, Salazar M, Candelario-Mckeown J, Foltynie T. Sibley KG, et al. Among authors: girges c. Mov Disord Clin Pract. 2021 Mar 8;8(3):489-490. doi: 10.1002/mdc3.13167. eCollection 2021 Apr. Mov Disord Clin Pract. 2021. PMID: 33816687 Free PMC article. No abstract available.
Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.
Vijiaratnam N, Girges C, Auld G, Chau M, Maclagan K, King A, Skene S, Chowdhury K, Hibbert S, Morris H, Limousin P, Athauda D, Carroll CB, Hu MT, Silverdale M, Duncan GW, Chaudhuri R, Lo C, Del Din S, Yarnall AJ, Rochester L, Gibson R, Dickson J, Hunter R, Libri V, Foltynie T. Vijiaratnam N, et al. Among authors: girges c. BMJ Open. 2021 May 28;11(5):e047993. doi: 10.1136/bmjopen-2020-047993. BMJ Open. 2021. PMID: 34049922 Free PMC article.
Long-term success of low-frequency subthalamic nucleus stimulation for Parkinson's disease depends on tremor severity and symptom duration.
Vijiaratnam N, Girges C, Wirth T, Grover T, Preda F, Tripoliti E, Foley J, Scelzo E, Macerollo A, Akram H, Hyam J, Zrinzo L, Limousin P, Foltynie T. Vijiaratnam N, et al. Among authors: girges c. Brain Commun. 2021 Jul 28;3(3):fcab165. doi: 10.1093/braincomms/fcab165. eCollection 2021. Brain Commun. 2021. PMID: 34396114 Free PMC article.
23 results